No significant differences were observed in clinical status or overall mortality between patients treated with convalescent plasma and those who received placebo. (PlasmAr ClinicalTrials.gov number, NCT04383535. opens in new tab.) Source: A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia | NEJM